ClinicalTrials.Veeva

Menu

Sodium Channel Mutations in Patient With the Anterior Cutaneous Nerve Entrapment Syndrome (ACNES) (Nav-ACNES)

M

Maxima Medical Center

Status

Enrolling

Conditions

Chronic Pain Syndrome
Anterior Cutaneous Nerve Entrapment Syndrome
Nerve Entrapment Syndrome

Treatments

Other: Sodium channel mutation

Study type

Observational

Funder types

Other

Identifiers

NCT05877274
NL84021.015.23

Details and patient eligibility

About

The goal of this observational study is to learn about sodium channel (Nav) mutations in patients with the Anterior Cutaneous Nerve Entrapment Syndrome (ACNES). This study will give more insight into the pathophysiology of ACNES, which is still largely unknown.

The primary objective is to determine if there are mutations of Nav1.7 and Nav1.8 in patients with ACNES. Therefore, one blood sample will be drawn, in which the mutations will be analyzed.

Enrollment

50 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

In order to be eligible to participate in this study, a subject must be diagnosed with ACNES and receive treatment at our outpatient clinic. Additionally, subject has to meet one of the following criteria:

  • Known to have a first- or second-degree relative with ACNES;
  • Have more than one recurrence of ACNES after a pain free period or ACNES at multiple locations in the abdominal wall;
  • Persistent pain after posterior neurectomy.

Exclusion criteria

  • Inability to understand Dutch language.
  • Known neuromuscular or neurodegenerative disease.

Trial design

50 participants in 1 patient group

Patients with ACNES
Description:
Patients with ACNES who fulfill the inclusion criteria.
Treatment:
Other: Sodium channel mutation

Trial contacts and locations

1

Loading...

Central trial contact

Tom ten Have, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems